Cited by 142Prenatal Screening and DiagnosticsCancer Genomics and DiagnosticsMaternal Mental Health During Pregnancy and Postpartum

Fetal DNA in maternal plasma: biology and diagnostic applications

Lo, Y M Dennis·2000·Clinical Chemistry

Abstract

BACKGROUND: Molecular analysis of plasma DNA during human pregnancy has led to the discovery that maternal plasma contains both fetal and maternal DNA. This valuable source of fetal DNA opens up new possibilities for noninvasive prenatal diagnosis. APPROACH: Published data from the last 3 years demonstrating the feasibility and utility of analyzing fetal DNA in maternal plasma are reviewed. CONTENT: The detection of fetal DNA in maternal plasma is much simpler and more robust than detecting fetal nucleated cells in maternal blood, and does not require prior enrichment. This approach has been shown to have application in the prenatal diagnosis of fetal rhesus D status, sex-linked disorders, and other paternally inherited genetic disorders. Abnormal fetal DNA concentrations in maternal plasma and serum have been found in common pregnancy-associated disorders, including preterm labor and preeclampsia, as well as in pregnancies complicated by fetal trisomy 21. After delivery, fetal DNA is cleared rapidly from maternal plasma, with a half-life in the order of minutes. These clearance kinetics exhibit an important difference from fetal cell clearance, where long-term persistence has been demonstrated. SUMMARY: It has been only 3 years since fetal DNA was first detected in maternal plasma, and much remains to be learned about the biology of this phenomenon. In addition, additional diagnostic applications beyond those discussed here can be expected in the near future.

Integrity signals

Registry

Crossref · 10.1093/clinchem/46.12.1903

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since the mid-1980s, prenatal treatment with high doses of dexamethasone has been proposed for pregnant women with a fetus at risk for classic CAH using a protocol of 20 μg/kg/day, maximum 1.5 mg/day, aiming to prevent prenatal virilization of the external genitalia in affected girls.

    “Since the mid-1980's, prenatal treatment with high doses of Dex has been proposed for to pregnant women with a fetus at risk for classic CAH using a treatment protocol of 20 µg/kg/day, maximum 1.5 mg/day, with the aim of preventing prenatal virilization of the external genitalia in affected girls (313,317,440).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lo, Y. M. D.
Affiliations
Chinese University of Hong Kong (HK)
Corresponding author
Lo, Y M Dennis
Venue
Clinical Chemistry
Published
2000-12-01
Volume
46
Issue
12
Pages
1903-1906
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2132158935
Cited by
142
References
43
Citations by year
2026: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 6
FWCI
9.19
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
fetal DNA, maternal plasma, cell-free fetal DNA, noninvasive prenatal diagnosis, sex-linked disorders, preterm labor, preeclampsia, Down syndrome
MeSH terms
DNA, Female, Fetus, Humans, Maternal-Fetal Exchange, Pregnancy, Prenatal Diagnosis, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review